Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

GLOW vs SS-31

GLOW and SS-31 are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Cellular Longevity
ClassThree-component dermal research blend — GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg (70 mg total)Mitochondria-targeting aromatic-cationic tetrapeptide (cardiolipin-binding)
Molecular weightNot specified639.81 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasDermatological, Cellular LongevityCellular Longevity, Metabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for 2–3 weeks at 2–8 °C — set by TB-500 and GHK-Cu rather than by BPC-157, which alone would tolerate longer.Commonly worked with for 3-4 weeks at 2-8 °C.
Lead degradation routeCopper dissociation from the GHK-Cu component at acidic pH or on contact with chelators such as EDTA — visible as the blue colour fading, and the single most consequential failure mode given GHK-Cu is 71% of the fill.Adsorptive loss to plasticware from the cationic charge — the main practical concern.
Freeze–thawAliquot on reconstitution. The three components degrade on independent schedules, so repeated cycles shift the ratio as well as reducing total content.Tolerant; the unnatural residues resist degradation. Aliquot as standard practice.
Light sensitivityProtect from light — required by both the GHK-Cu and TB-500 components.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: GLOW is three-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg (70 mg total), while SS-31 is mitochondria-targeting aromatic-cationic tetrapeptide (cardiolipin-binding) — different molecular classes with different handling consequences; their leading degradation routes differ (copper dissociation from the ghk-cu component at acidic ph or on contact with chelators such as edta for GLOW, adsorptive loss to plasticware from the cationic charge for SS-31), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

GLOW — origin

GLOW combines three of the most-studied compounds in tissue and dermal research into one 70 mg vial: GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg). The rationale is mechanistic complementarity — GHK-Cu research centres on collagen and extracellular matrix synthesis, BPC-157 on angiogenesis and growth-factor signalling, and TB-500 on actin-mediated cell migration. Three non-overlapping routes into the same repair biology.

SS-31 — origin

SS-31 (Elamipretide) is a Szeto-Schiller aromatic-cationic tetrapeptide (D-Arg-2',6'-dimethyltyrosine-Lys-Phe-NH2) that concentrates in the inner mitochondrial membrane and binds cardiolipin, the lipid unique to that membrane. Its structure is the reason it is studied specifically at the mitochondrion rather than as a general antioxidant.

GLOW research themes

Collagen and matrix synthesis (GHK-Cu)

The majority component, with the deepest dermal literature — collagen and glycosaminoglycan synthesis in fibroblast models.

Angiogenesis and growth-factor signalling (BPC-157)

Studied around vessel formation and growth-factor pathways in tissue-repair models.

Cell migration (TB-500)

Actin sequestration and directed cell movement — how cells reach a tissue defect.

Complementary-pathway design

The three components act through genuinely non-overlapping mechanisms, which is the rationale for combining them.

SS-31 research themes

Cardiolipin binding

Studied for selective association with cardiolipin in the inner mitochondrial membrane, the basis of its mitochondrial targeting.

Electron transport efficiency

Examined for effects on mitochondrial energy production in research models of mitochondrial dysfunction.

Oxidative stress

Investigated around reactive-oxygen-species handling at the mitochondrion.

GLOW handling

  • Never reconstitute in acidic diluent — this dissociates copper from the GHK-Cu component, which is the majority of the vial.
  • Keep chelating agents such as EDTA out of any buffer used with GLOW; they will strip the copper.
  • Treat colour as data: clear, even blue is correct. Pale, colourless or green means the GHK-Cu component has degraded.
  • Protect from light for the TB-500 and GHK-Cu components, and minimise headspace exposure.
  • Do not subdivide the dry cake — three co-lyophilized components do not partition evenly in powder form.

SS-31 handling

  • Reach room temperature before opening.
  • Use low-bind labware and buffers at low working concentrations to limit adsorption of the cationic peptide.
  • Aliquot and refrigerate.

Both third-party tested

Every Popular Peptides batch of GLOW and SS-31 is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

GLOW reference

Full GLOW reference GLOW storage GLOW reconstitution GLOW calculatorGLOW product details

SS-31 reference

Full SS-31 reference SS-31 storage SS-31 reconstitution SS-31 calculatorSS-31 product details

Related comparisons

5-Amino-1MQ vs GLOW5-Amino-1MQ vs SS-31BPC-157 vs GLOWCJC-1295 (No DAC) vs SS-31CJC-1295 + Ipamorelin vs SS-31DSIP vs GLOWDSIP vs SS-31Epitalon vs GLOW

GLOW and SS-31 are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.